Rosenkranz S - Search Results

1

Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension.

Dumitrescu D, Seck C, Möhle L, Erdmann E, Rosenkranz S. Dumitrescu D, et al. Among authors: rosenkranz s. Int J Cardiol. 2012 Jan 26;154(2):205-6. doi: 10.1016/j.ijcard.2011.10.064. Epub 2011 Nov 21. Int J Cardiol. 2012. PMID: 22104986 Clinical Trial. No abstract available.

2

Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon.

Rosenkranz S, Diet F, Karasch T, Weihrauch J, Wassermann K, Erdmann E. Rosenkranz S, et al. Ann Intern Med. 2003 Nov 18;139(10):871-3. doi: 10.7326/0003-4819-139-10-200311180-00030. Ann Intern Med. 2003. PMID: 14623635 No abstract available.

3

Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease.

Caglayan E, Huntgeburth M, Karasch T, Weihrauch J, Hunzelmann N, Krieg T, Erdmann E, Rosenkranz S. Caglayan E, et al. Among authors: rosenkranz s. Arch Intern Med. 2006 Jan 23;166(2):231-3. doi: 10.1001/archinte.166.2.231. Arch Intern Med. 2006. PMID: 16432094 Clinical Trial.

4

[Novel indications for phosphodiesterase type 5 inhibitors].

Rosenkranz S, Caglayan E, Erdmann E. Rosenkranz S, et al. Med Klin (Munich). 2007 Aug 15;102(8):617-30. doi: 10.1007/s00063-007-1078-4. Med Klin (Munich). 2007. PMID: 17694282 Review. German.

5

Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients.

Pfister R, Diedrichs H, Schiedermair A, Rosenkranz S, Hellmich M, Erdmann E, Schneider CA. Pfister R, et al. Among authors: rosenkranz s. Eur J Heart Fail. 2008 Mar;10(3):315-20. doi: 10.1016/j.ejheart.2008.01.009. Epub 2008 Mar 4. Eur J Heart Fail. 2008. PMID: 18304872 Free article.

6

Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension.

ten Freyhaus H, Dumitrescu D, Bovenschulte H, Erdmann E, Rosenkranz S. ten Freyhaus H, et al. Among authors: rosenkranz s. Clin Res Cardiol. 2009 Apr;98(4):265-7. doi: 10.1007/s00392-009-0752-3. Epub 2009 Feb 13. Clin Res Cardiol. 2009. PMID: 19219392 No abstract available.

7

Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study.

Er F, Aslan O, Caglayan E, Gassanov N, Nia AM, Erdmann E, Rosenkranz S. Er F, et al. Among authors: rosenkranz s. Clin Res Cardiol. 2010 Jun;99(6):369-73. doi: 10.1007/s00392-010-0129-7. Epub 2010 Feb 24. Clin Res Cardiol. 2010. PMID: 20180126

8

[PDE5 inhibitors in the treatment of pulmonary hypertension].

Dumitrescu D, Erdmann E, Rosenkranz S. Dumitrescu D, et al. Among authors: rosenkranz s. Pharm Unserer Zeit. 2010 Sep;39(5):391-6. doi: 10.1002/pauz.201000385. Pharm Unserer Zeit. 2010. PMID: 20818689 Review. German. No abstract available.

9

Extensive hepatic portal venous gas and gastric emphysema after successful resuscitation.

Reuter H, Bangard C, Gerhardt F, Rosenkranz S, Erdmann E. Reuter H, et al. Among authors: rosenkranz s. Resuscitation. 2011 Feb;82(2):238-9. doi: 10.1016/j.resuscitation.2010.10.028. Epub 2010 Dec 4. Resuscitation. 2011. PMID: 21134710 No abstract available.

10

Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing.

Dumitrescu D, Oudiz RJ, Karpouzas G, Hovanesyan A, Jayasinghe A, Hansen JE, Rosenkranz S, Wasserman K. Dumitrescu D, et al. Among authors: rosenkranz s. PLoS One. 2010 Dec 13;5(12):e14293. doi: 10.1371/journal.pone.0014293. PLoS One. 2010. PMID: 21179195 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

619 results

Search Page